Classic Benjamin Graham Stock Screener
Free Value Investing for Intelligent Investors across Global Equity Markets, as recommended by Warren Buffett.
| Company Name | MIC | HQ | Fiscal Year | Last Updated | Curr Code | Previous Close | Graham Number | Graham Number(%) | NCAV/ NetNet | NCAV/ NetNet(%) | Graham Grade | Intrinsic Value | Intrinsic Value(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 141 | Aclaris Therapeutics Inc (ACRS) | XNAS | US | 2024-12-31 | 2 days ago | USD | 3.57 | 0.00 | 0.00% | 0.57 | 15.89% | Ungraded | 0.00 | 0.00% |
| 142 | AcelRx Pharmaceuticals Inc (ACRX) | XNAS | US | 2022-12-31 | 2 years ago | USD | 0.99 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 143 | Acacia Research Corp (ACTG) | XNAS | US | 2024-12-31 | 2 days ago | USD | 4.20 | 0.00 | 0.00% | 1.86 | 44.27% | NCAV (Net-Net) | 1.86 | 44.27% |
| 144 | Anworth Mortgage Asset Corp (ANH) | 2020-12-31 | 4 years ago | USD | 0.00 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% | ||
| 145 | Adaptimmune Therapeutics PLC (ADAP) | XNAS | GB | 2024-12-31 | 3 months ago | USD | 0.06 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 146 | Atomera Inc (ATOM) | XNAS | US | 2024-12-31 | 2 days ago | USD | 2.57 | 0.00 | 0.00% | 0.75 | 29.35% | Ungraded | 0.00 | 0.00% |
| 147 | AnaptysBio Inc (ANAB) | XNAS | US | 2024-12-31 | 2 days ago | USD | 49.73 | 0.00 | 0.00% | 0.62 | 1.25% | Ungraded | 0.00 | 0.00% |
| 148 | Ashland Inc (ASH) | XNYS | US | 2025-09-30 | 2 days ago | USD | 64.16 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 149 | Arco Platform Ltd (ARCE) | XNAS | BR | 2022-12-31 | 2 years ago | BRL | 0.00 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 150 | Ambarella Inc (AMBA) | XNAS | US | 2025-01-31 | 2 days ago | USD | 63.64 | 0.00 | 0.00% | 4.60 | 7.23% | Ungraded | 0.00 | 0.00% |